comparemela.com
Home
Live Updates
Guselkumab for the Treatment of Crohn Disease, with Remo Panaccione, MD : comparemela.com
Guselkumab for the Treatment of Crohn Disease, with Remo Panaccione, MD
In this interview, Remo Panaccione, MD, discusses results from the long-term extension of the GALAXI phase 2 study for guselkumab in Crohn disease and their implications in clinical practice.
Related Keywords
Remo Panaccione
,
University Of Calgary
,
Johnson
,
Drug Administration
,
Johnson Innovative Medicines
,
United European Gastroenterology Week
,
Inflammatory Bowel Disease Unit
,
Severely Active Crohn
,
Participants With Moderately
,
Demonstrates Long Term Benefit
,
Crohn Disease
,
Cd
,
Crohn X27s Disease
,
Ibd
,
Inflammatory Bowel Disease
,
Guselkumab
,
Galaxi
,
Phase 2
,
Study
,
Trial
,
Tremfya
,
comparemela.com © 2020. All Rights Reserved.